Back to the NewsWire

App Dealroom

Published September 4, 2026 · Updated September 5, 2026

Biotech Clearmind buys 51% of EV charging startup for $2.5M | Dealroom.co

The move marks a sharp pivot for Clearmind, a company focused on psychedelic-based treatments, into the electric vehicle charging market. Taking a.

Read the full story at App Dealroom

Surfaced by this Google Alert

  • Psychedelic biotech